Nicotine as a Conditioned Stimulus: Impact of Attention-Deficit/Hyperactivity Disorder Medications

Experimental and Clinical Psychopharmacology

Volumn 15, Issue 5, 2007, Pages 501-509

  Reichel, Carmela M ^a   Linkugel, Jessica D ^a   Bevins, Rick A ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

dopamine; drug discrimination; interoceptive Pavlovian conditioning; nicotinic acetylcholine receptors; norepinephrine

Indexed keywords

AMFEBUTAMONE; ATOMOXETINE; COCAINE; DOPAMINE UPTAKE INHIBITOR; METHYLPHENIDATE; NICOTINE; VANOXERINE;

ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; CIGARETTE SMOKING; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; MALE; NONHUMAN; RAT; RISK ASSESSMENT;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR, ANIMAL; BUPROPION; COCAINE; CONDITIONING (PSYCHOLOGY); CONDITIONING, OPERANT; DISCRIMINATION LEARNING; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENERALIZATION (PSYCHOLOGY); MALE; METHYLPHENIDATE; NICOTINE; NICOTINIC ANTAGONISTS; PIPERAZINES; PROPYLAMINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 36048970084     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.15.5.501     Document Type: Article

References (51)

1. Ascher J.A., Cole J.O., Colin J.N., Feighner J.P., Ferris R.M., Fibiger H.C., et al. Bupropion: A review of its mechanism of antidepressant activity. Journal of Clinical Psychiatry 56 (1995) 395-401
2. Besheer J., Palmatier M.I., Metschke D.M., and Bevins R.A. Nicotine as a signal for the presence or absence of sucrose reward: A Pavlovian drug appetitive conditioning preparation in rats. Psychopharmacology 172 (2004) 108-117
3. Bevins R.A., and Palmatier M.I. Extending the role of associative learning processes in nicotine addiction. Behavioral and Cognitive Neuroscience Reviews 3 (2004) 143-158
4. Bevins R.A., Penrod R.D., and Reichel C.M. Nicotine does not produce state-dependent effects on learning in a Pavlovian appetitive goal tracking task with rats. Behavioural Brain Research 177 (2007) 134-141
5. Boakes R.A. Performance on learning to associate a stimulus with positive reinforcement. In: Davis H., and Hurwitz H.M.B. (Eds). Operant-Pavlovian interactions (1977), Erlbaum, Hillsdale, NJ 67-101
6. Brandsgaard R., Barrett J.E., and Rosenzweig-Lipson S. Pharmacological characterization of the discriminative stimulus effects of the potassium channel blocker 4-aminopyridine in rats. Journal of Pharmacology and Experimental Therapeutics 295 (2000) 295-391
7. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H., et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27 (2002) 699-711
8. Clements K., Glautier S., Stolerman I.P., White J.-A.W., and Taylor C. Classical conditioning in humans: Nicotine as CS and alcohol as US. Human Psychopharmacology 11 (1996) 85-95
9. Corrigall W.A., Coen K.M., and Adamson K.L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Research 653 (1994) 278-284
10. Davis J.A., and Gould T.J. Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning. Neuropsychopharmacology 32 (2007) 2011-2019
11. Davis J.A., James J.R., Siegel S.J., and Gould T.J. Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. Journal of Neuroscience 25 (2005) 8708-8713
12. de Leon J., and Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research 76 (2005) 135-157
13. Desai R.I., Barber D.J., and Terry P. Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats. Psychopharmacology 167 (2003) 335-343
14. Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. European Journal of Pharmacology 375 (1999) 13-30
15. Farwell B.J., and Ayres J.J.B. Stimulus-reinforcer and response-reinforcer relations in the control of conditioned appetitive headpoking ("goal tracking") in rats. Learning and Motivation 10 (1979) 295-312
16. Fu Y., Matta S.G., James T.J., and Sharp B.M. Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors. Journal of Pharmacology and Experimental Therapeutics 284 (1998) 1188-1196
17. Gasior M., Bergman J., Kallman M.J., and Paronis C.A. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys. Neuropsychopharmacology 30 (2005) 758-764
18. Geier A., Mucha R.F., and Pauli P. Appetitive nature of drug cues confirmed with physiological measures in a model using pictures of smoking. Psychopharmacology 150 (2000) 283-291
19. Glassman A.H., Helzer J.E., Covey L.S., Cottler L.B., Stetner F., Tipp J.E., et al. Smoking, smoking cessation, and major depression. Journal of the American Medical Association 264 (1990) 1546-1549
20. Gould T.J., Rukstalis M., and Lewis M.C. Atomoxetine and nicotine enhance prepulse inhibition of acoustic startle in C57BL/6 mice. Neuroscience Letters 377 (2005) 85-90
21. Heil S.H., Holmes H.W., Bickel W.K., Higgins S.T., Badger G.J., Laws H.F., and Faries D.E. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug and Alcohol Dependence 67 (2002) 149-156
22. Katz J.L., Izenwasser S., and Terry P. Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects. Psychopharmacology 148 (2000) 90
23. Kuczenski R., and Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine. Journal of Neurochemistry 68 (1997) 2032-2037
24. Lamb R.J., and Griffiths R.R. Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine. Psychopharmacology 102 (1990) 183-190
25. Lazev A.B., Herzog T.A., and Brandon T.H. Classical conditioning of environmental cues to cigarette smoking. Experimental and Clinical Psychopharmacology 7 (1999) 56-63
26. Lile J.A., Stoops W.W., Durell T.M., Glaser P.E.A., and Rush C.R. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans. Experimental and Clinical Psychopharmacology 14 (2006) 136-147
27. Mansbach R.S., Rovetti C.C., and Freedland C.S. The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus. Drug and Alcohol Dependence 52 (1998) 125-134
28. Mattiuz E.L., Ponsler G.D., Barbuch R.J., Wood P.G., Mullen J.H., Shugert R.L., et al. Disposition and metabolic fate of atomoxetine hydrochloride: Pharmacokinetics, metabolism, and excretion in the Fisher 344 rat and beagle dog. Journal of Pharmacology and Experimental Therapeutics 31 (2003) 88-97
29. Milberger S., Biederman J., Faraone S.V., Chen L., and Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 36 (1997) 37-44
30. Miller D.K., Sumithran S.P., and Dwoskin L.P. Bupropion inhibits nicotine-evoked [3H]overflow from rat striatal slices preloaded with [3H]dopamine and from rat hippocampal slices preloaded with [3H]norepinephrine. Journal of Pharmacological and Experimental Therapeutics 302 (2002) 1113-1122
31. Miller D.K., Wong E.H.F., Chesnut M.D., and Dwoskin L.P. Reboxetine: Functional inhibition of monoamine transporters and nicotinic acetylcholine receptors. Journal of Pharmacological and Experimental Therapeutics 302 (2002) 687-695
32. Morris C.D., Giese A.A., Turnbull J.J., Dickinson M., and Johnson-Nagel N. Predictors of tobacco use among persons with mental illnesses in a statewide population. Psychiatric Services 57 (2006) 1035-1038
33. Murray J.E., and Bevins R.A. Behavioral and neuropharmacological characterization of nicotine as a conditioned stimulus. European Journal of Pharmacology 561 (2007) 91-104
34. National Research Council. Guide for the care and use of laboratory animals (1996), National Academy Press, Washington, DC
35. Nomikos G.G., Damsma G., Wenkstern D., and Fibiger H.C. Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. Neuropsychopharmacology 7 (1992) 7-14
36. Pomerleau C.S., Downey K.K., Snedecor S.M., Mehringer A.M., Marks J.L., and Pomerleau O.F. Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology. Addictive Behaviors 28 (2003) 1149-1157
37. Pomerleau C.S., Marks J.L., and Pomerleau O.F. Who gets what symptom? Effects of psychiatric cofactors and nicotine dependence on patterns of smoking withdrawal symptomatology. Nicotine & Tobacco Research 2 (2000) 275-280
38. Potter A.S., and Newhouse P.A. Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder. Psychopharmacology 176 (2004) 183-194
39. Potter P.E., Thorne B., and Gaughan C. Modulation of hippocampal norepinephrine release by cholinergic agonists is altered by AF64A lesion. Brain Research Bulletin 42 (1997) 153-160
40. Pritchard W.S., Robinson J.H., Guy T.D., Davis R.A., and Stiles M.F. Assessing the sensory role of nicotine in cigarette smoking. Psychopharmacology 127 (1996) 55-62
41. Rauhut A.S., Mullins S.N., Dwoskin L.P., and Bardo M.T. Reboxetine: Attenuation of intravenous nicotine self-administration in rats. Journal of Pharmacological and Experimental Therapeutics 303 (2002) 664-672
42. Rose J.E., and Levin E.D. Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking. British Journal of Addiction 86 (1991) 605-609
43. Stolerman I.P., and Shoaib M. The neurobiology of tobacco addiction. Trends in Pharmacological Sciences 12 (1991) 467-473
44. Swanson C.J., Perry K.W., Koch-Krueger S., Katner J., Svensson D.A., and Bymaster F.P. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several regions of the rat. Neuropharmacology 50 (2006) 755-760
45. Tella S.R., Ladenheim B., and Cadet J.L. Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine. Journal of Pharmacology and Experimental Therapeutics 281 (1997) 508-513
46. Terry P., Witkin J.M., and Katz J.K. Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. Journal of Pharmacology and Experimental Therapeutics 271 (1994) 1041-1048
47. Troisi II J.R. Pavlovian-instrumental transfer of the discriminative stimulus effects of nicotine and ethanol in rats. Psychological Record 56 (2006) 499-512
48. Tzavara E.T., Bymaster F.P., Overshiner C.D., Davis R.J., Perry K.W., Wolff M., et al. Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine. Molecular Psychiatry 11 (2006) 187-195
49. Wee S., and Woolverton W.L. Evaluation of the reinforcing effects of atomoxetine in monkeys: Comparison to methylphenidate and desipramine. Drug and Alcohol Dependence 75 (2004) 271-276
50. Wilkinson J.L., Murray J.E., Li C., Wiltgen S.M., Penrod R.D., Berg S.A., et al. Interoceptive Pavlovian conditioning with nicotine as the conditional stimulus varies as a function of the number of conditioning trials and unpaired sucrose deliveries. Behavioural Pharmacology 17 (2006) 161-172
51. Williams J.M., and Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors 29 (2004) 1067-1083